Impact of Circulating Tumor DNA Early Detection and Serial Monitoring in the Management of Stage I to III Colorectal Cancer

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Feb 5

PMID 32016033

Citations 2

Authors

Diana Bello Roufai

Francois-Clement Bidard

Affiliations

Soon will be listed here.

Citing Articles

Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies.

Zhang S, Brazel D, Kumar P, Schafer L, Eidenschink B, Senthil M J Gastrointest Oncol. 2022; 12(6):2643-2652.

PMID: 35070394 PMC: 8748058. DOI: 10.21037/jgo-21-484.

Comprehensive analysis of 5-hydroxymethylcytosine in zw10 kinetochore protein as a promising biomarker for screening and diagnosis of early colorectal cancer.

Dang Y, Hu D, Xu J, Li C, Tang Y, Yang Z Clin Transl Med. 2020; 10(3):e125.

PMID: 32628818 PMC: 7418801. DOI: 10.1002/ctm2.125.

References

Frattini M, Balestra D, Verderio P, Gallino G, Leo E, Sozzi G . Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients. J Clin Oncol. 2005; 23(13):3163-4. DOI: 10.1200/JCO.2005.05.430. View

Dawson S, Tsui D, Murtaza M, Biggs H, Rueda O, Chin S . Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013; 368(13):1199-209. DOI: 10.1056/NEJMoa1213261. View

Cabel L, Proudhon C, Mariani P, Tzanis D, Beinse G, Bieche I . Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?. Eur J Surg Oncol. 2017; 43(5):949-962. DOI: 10.1016/j.ejso.2017.01.010. View

Scholer L, Reinert T, Orntoft M, Kassentoft C, Arnadottir S, Vang S . Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer. Clin Cancer Res. 2017; 23(18):5437-5445. DOI: 10.1158/1078-0432.CCR-17-0510. View

Nguyen D, Bos P, Massague J . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9(4):274-84. DOI: 10.1038/nrc2622. View

Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J . Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017; 9(403). PMC: 6714979. DOI: 10.1126/scitranslmed.aan2415. View

Lin J, Lin P, Lin C, Jiang J, Yang S, Liang W . Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors. Ann Surg Oncol. 2014; 21 Suppl 4:S680-6. DOI: 10.1245/s10434-014-3804-5. View

MOERTEL C, Fleming T, Macdonald J, Haller D, Laurie J, Tangen C . An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993; 270(8):943-7. View

Lecomte T, Berger A, Zinzindohoue F, Micard S, Landi B, Blons H . Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer. 2002; 100(5):542-8. DOI: 10.1002/ijc.10526. View

10.

Bachet J, Bouche O, Taieb J, Dubreuil O, Garcia M, Meurisse A . RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study. Ann Oncol. 2018; 29(5):1211-1219. DOI: 10.1093/annonc/mdy061. View

11.

Reinert T, Vesterman Henriksen T, Christensen E, Sharma S, Salari R, Sethi H . Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. JAMA Oncol. 2019; 5(8):1124-1131. PMC: 6512280. DOI: 10.1001/jamaoncol.2019.0528. View

12.

Madic J, Kiialainen A, Bidard F, Birzele F, Ramey G, Leroy Q . Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients. Int J Cancer. 2014; 136(9):2158-65. DOI: 10.1002/ijc.29265. View

13.

Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I . Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016; 8(346):346ra92. PMC: 5346159. DOI: 10.1126/scitranslmed.aaf6219. View

14.

Speicher M, Pantel K . Tumor signatures in the blood. Nat Biotechnol. 2014; 32(5):441-3. DOI: 10.1038/nbt.2897. View

15.

Bazan V, Bruno L, Augello C, Agnese V, Calo V, Corsale S . Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol. 2006; 17 Suppl 7:vii84-90. DOI: 10.1093/annonc/mdl958. View

16.

Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N . Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014; 6(224):224ra24. PMC: 4017867. DOI: 10.1126/scitranslmed.3007094. View

17.

Whiteside T . Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem. 2016; 74:103-41. PMC: 5382933. DOI: 10.1016/bs.acc.2015.12.005. View

18.

Thery L, Meddis A, Cabel L, Proudhon C, Latouche A, Pierga J . Circulating Tumor Cells in Early Breast Cancer. JNCI Cancer Spectr. 2019; 3(2):pkz026. PMC: 6649836. DOI: 10.1093/jncics/pkz026. View

19.

Reinert T, Scholer L, Thomsen R, Tobiasen H, Vang S, Nordentoft I . Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut. 2015; 65(4):625-34. DOI: 10.1136/gutjnl-2014-308859. View

20.

Bidard F, Kiavue N, Ychou M, Cabel L, Stern M, Madic J . Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial. Cells. 2019; 8(6). PMC: 6627974. DOI: 10.3390/cells8060516. View